1. Medical Department of Hematology, Oncology, and Tumor Immunology, and Molekulares Krebsforschungszentrum, Charité - Universitätsmedizin Berlin, Berlin, Germany;
2. Center of Cancer Research, Binzhou Medical University Hospital, Binzhou, People’s Republic of China;
3. Screening Unit, Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany;
4. Max-Delbrück-Center for Molecular Medicine, Helmholtz Association, Berlin, Germany;
5. Institute for Molecular Tumor Biology, Westfälische Wilhelms-Universität, Münster, Germany;
6. Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; and
7. Berlin Institute of Health, Berlin, Germany